Trademark: 97341667
Word
NGMBIO
Status Date
Thursday, May 23, 2024
Filing Date
Thursday, March 31, 2022
Published for Opposition
Tuesday, April 11, 2023
5 Pharmaceutical preparations for the prevention and treatment of cancer, retinal, liver, metabolic, autoimmune, cardiovascular, neurological, immune, musculoskeletal, endocrine and hematological diseases and disorders
44 Providing medical information relating to cancer, retinal diseases and liver and metabolic diseases
42 Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Apr 4, 2022
New Application Entered
Apr 6, 2022
New Application Office Supplied Data Entered
Aug 4, 2022
Assigned To Examiner
Aug 10, 2022
Non-Final Action Written
Aug 10, 2022
Non-Final Action E-Mailed
Aug 10, 2022
Notification Of Non-Final Action E-Mailed
Feb 1, 2023
Teas Response To Office Action Received
Feb 1, 2023
Correspondence Received In Law Office
Feb 2, 2023
Teas/Email Correspondence Entered
Mar 2, 2023
Approved For Pub - Principal Register
Mar 22, 2023
Notification Of Notice Of Publication E-Mailed
Apr 11, 2023
Published For Opposition
Apr 11, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 6, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 17, 2023
Sou Teas Extension Received
Nov 17, 2023
Sou Extension 1 Filed
Nov 17, 2023
Sou Extension 1 Granted
May 23, 2024
Sou Teas Extension Received
May 23, 2024
Sou Extension 2 Filed
May 23, 2024
Sou Extension 2 Granted
May 24, 2024
Notice Of Approval Of Extension Request E-Mailed
Nov 21, 2023
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
